Global Antihemophilic Factor Market Data Survey Report 2025

November 2018 | 77 pages | ID: G3B96EF4D46EN
HeyReport

Abstracts

Summary

The global Antihemophilic Factor market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:

Global market size and forecast

Regional market size, production data and export & import

Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)

Major Application

Major Type

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:

• Shire (Baxter)
• Bayer
• CSL
• Pfizer
• Grifols
• Biogen
• Biogen
• NovoNordisk
• Greencross
• Kedrion
• BPL
• Hualan Bio
• RAAS

Major applications as follows:

• Hospital
• Pharmacy

Major Type
as follows:

• Recombinant Factor VIII
• Plasma-derived Factor VIII

Regional market size, production data and Trade:

• Asia-Pacific
• North America
• Europe
• South America
• Middle East & Africa

Contents

1 GLOBAL MARKET OVERVIEW

1.1 Scope of Statistics
  1.1.1 Scope of Products
  1.1.2 Scope of Manufacturers
  1.1.3 Scope of Application
  1.1.5 Scope of Regions/Countries
1.2 Global Market Size

2 REGIONAL MARKET

2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 KEY MANUFACTURERS

3.1 Shire (Baxter)
  3.1.2 Company Information
  3.1.2 Product Specifications
  3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Bayer
  3.2.1 Company Information
  3.2.2 Product Specifications
  3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 CSL
  3.3.1 Company Information
  3.3.2 Product Specifications
  3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Pfizer
  3.4.1 Company Information
  3.4.2 Product Specifications
  3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Grifols
  3.5.1 Company Information
  3.5.2 Product Specifications
  3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Biogen
  3.6.1 Company Information
  3.6.2 Product Specifications
  3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Biogen
  3.7.1 Company Information
  3.7.2 Product Specifications
  3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 NovoNordisk
  3.8.1 Company Information
  3.8.2 Product Specifications
  3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Greencross
  3.9.1 Company Information
  3.9.2 Product Specifications
  3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Kedrion
  3.10.1 Company Information
  3.10.2 Product Specifications
  3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 BPL
3.12 Hualan Bio
3.13 RAAS

4 MAJOR APPLICATION

4.1 Hospital
  4.1.1 Overview
  4.1.2 Hospital Market Size and Forecast
4.2 Pharmacy
  4.2.1 Overview
  4.2.2 Pharmacy Market Size and Forecast

5 MARKET BY TYPE

5.1 Recombinant Factor VIII
  5.1.1 Overview
  5.1.2 Recombinant Factor VIII Market Size and Forecast
5.2 Plasma-derived Factor VIII
  5.2.1 Overview
  5.2.2 Plasma-derived Factor VIII Market Size and Forecast

6 CONCLUSION

List Of Tables

LIST OF TABLES

Tab REGIONAL PRODUCTION 2012-2017 (MILLION USD)
Tab Regional Production 2012-2017 (Volume)
Tab Regional Demand and CAGR 2012-2017 (Million USD)
Tab Regional Demand and CAGR 2012-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Shire (Baxter)
Tab Sales Revenue, Volume, Price, Cost and Margin of Bayer
Tab Sales Revenue, Volume, Price, Cost and Margin of CSL
Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Tab Sales Revenue, Volume, Price, Cost and Margin of Grifols
Tab Sales Revenue, Volume, Price, Cost and Margin of Biogen
Tab Sales Revenue, Volume, Price, Cost and Margin of Biogen
Tab Sales Revenue, Volume, Price, Cost and Margin of NovoNordisk
Tab Sales Revenue, Volume, Price, Cost and Margin of Greencross
Tab Sales Revenue, Volume, Price, Cost and Margin of Kedrion
Tab Sales Revenue, Volume, Price, Cost and Margin of BPL
Tab Sales Revenue, Volume, Price, Cost and Margin of Hualan Bio
Tab Sales Revenue, Volume, Price, Cost and Margin of RAAS

List Of Figures

LIST OF FIGURES

Fig Global Antihemophilic Factor Market Size and CAGR 2012-2017 (Million USD)
Fig Global Antihemophilic Factor Market Size and CAGR 2012-2017 (Volume)
Fig Global Antihemophilic Factor Market Forecast and CAGR 2018-2025 (Million USD)
Fig Global Antihemophilic Factor Market Forecast and CAGR 2018-2025 (Volume)
Fig Hospital Market Size and CAGR 2012-2017 (Million USD)
Fig Hospital Market Size and CAGR 2012-2017 (Volume)
Fig Hospital Market Forecast and CAGR 2018-2025 (Million USD)
Fig Hospital Market Forecast and CAGR 2018-2025 (Volume)
Fig Pharmacy Market Size and CAGR 2012-2017 (Million USD)
Fig Pharmacy Market Size and CAGR 2012-2017 (Volume)
Fig Pharmacy Market Forecast and CAGR 2018-2025 (Million USD)
Fig Pharmacy Market Forecast and CAGR 2018-2025 (Volume)
Fig Recombinant Factor VIII Market Size and CAGR 2012-2017 (Million USD)
Fig Recombinant Factor VIII Market Size and CAGR 2012-2017 (Volume)
Fig Recombinant Factor VIII Market Forecast and CAGR 2018-2025 (Million USD)
Fig Recombinant Factor VIII Market Forecast and CAGR 2018-2025 (Volume)
Fig Plasma-derived Factor VIII Market Size and CAGR 2012-2017 (Million USD)
Fig Plasma-derived Factor VIII Market Size and CAGR 2012-2017 (Volume)
Fig Plasma-derived Factor VIII Market Forecast and CAGR 2018-2025 (Million USD)
Fig Plasma-derived Factor VIII Market Forecast and CAGR 2018-2025 (Volume)